license

Cyprumed and MSD Enter Licensing Agreement for Oral Peptide Therapeutics

MSD receives a non-exclusive license for Cyprumed's drug delivery technology for developing oral peptide therapeutics.

ECI Group Secures First 150kta Copolymer License

ECI Group recently announced the signing of a licensing agreement with Shaanxi Yanchang China Coal Yulin Energy & Chemical Co., Ltd. (YECC) to deliver a 150kta copolymer plant project using ECI Group’s proprietary hybrid reactor technology.

Air Liquide Takes MCC Butene License

NatureWorks Picks Plaxica’s D-lactic Acid Process